Badreddin Edris Net Worth & Insider Trades

Badreddin Edris - Chief Operating Officer, Springworks Therapeutics, Inc

As of January 10, 2023

What is Badreddin Edris's Net Worth?

The current estimated net worth of Springworks Therapeutics, Inc's Chief Operating Officer, Badreddin Edris, is estimated to be about $13.29M . Badreddin Edris owns about 301,541 units of Springworks Therapeutics, Inc common stock. In the last 3 years at Springworks Therapeutics, Inc, Badreddin Edris has sold an estimated value of $5.69M worth.

What is Badreddin Edris's Past Insider Trading?

Badreddin Edris's largest sale order was 32,000 units , worth over $2.73M on July 1, 2021. In total, Badreddin Edris has made about 8 transactions over 3 years of their time at Springworks Therapeutics, Inc. Badreddin Edris usually trades in January, with the busiest year in 2021.

Badreddin Edris

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Badreddin Edris's Salary in 2020?

As Chief Operating Officer of Springworks Therapeutics, Inc, Badreddin Edris has a total base salary of $409,500 . Badreddin Edris received compensation valued at about $2,744,080 in 2020 after becoming Chief Operating Officer. The vast majority of their compensation came in the form of option awards of $2,088,880 , other earnings, plans or compensations of $245,700 , and

What is Badreddin Edris's' Mailing Address?

  • Mailing address is C/o Springworks Therapeutics, Inc. 100 Washington Blvd. Stamford CT 06902 CT

Springworks Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Saqib Islam, J.D., 2020 $540,750 - - $6,788,860 $405,563 - $7,735,173
Saqib Islam, J.D., 2019 $480,115 - - $2,470,056 $334,750 - $3,284,921
Saqib Islam, J.D., 2018 $406,510 - $1,181,322 - $180,000 - $1,767,832
Francis I. Perier, Jr., M.B.A., 2020 $405,600 - - $1,566,660 $243,360 - $2,215,620
Francis I. Perier, Jr., M.B.A., 2019 $144,583 - - $2,150,821 $77,231 - $2,372,635
Badreddin Edris, Ph.D., 2020 $409,500 - - $2,088,880 $245,700 - $2,744,080
Badreddin Edris, Ph.D., 2019 $377,609 - - $222,126 $202,800 $107,895 $910,430
Badreddin Edris, Ph.D., 2018 $112,500 - $339,900 - $33,140 $37,735 $523,275
L. Mary Smith, Ph.D., 2020 $409,500 - - $1,566,660 $245,700 - $2,221,860
L. Mary Smith, Ph.D., 2019 $369,784 - - $180,051 $202,800 - $752,636
L. Mary Smith, Ph.D., 2018 $279,865 - $123,644 - $79,000 - $482,509
Herschel S. Weinstein, J.D. 2020 $348,333 - - $2,256,594 $194,180 - $2,799,107
Daniel Pichl, 2020 $145,833 - - $2,095,305 $73,990 - $2,315,128
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1773427/000110465921050515/tm2110663-2_def14a.htm

What are Springworks Therapeutics, Inc's Past Insider Trades?

Springworks Therapeutics, Inc's most recent insider trade came on September 14, 2022 by Orbimed Advisors Llc and Orbimed Capital GP Vi Llc who sold 153,897 units worth $4.92M . In the last 3 years, insiders at Springworks Therapeutics, Inc have sold an estimated value of $333.7M and bought an estimated value of $14.59M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Mary Smith, Chief Development Officer,  Saqib Islam, Chief Executive Officer,  and Orbimed Advisors Llc .

SpringWorks Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1